Contract Details
Entity Involved: Company's subsidiary Noumed Pharmaceuticals Pty Limited
Contract Type: Renewed long-term OTC Medicines Supply Agreement
Counterparty: One of Australia's leading, multi-billion-dollar pharmacy chains (international entity)
Key Contract Features:
- Expanded product portfolio
- Long agreement tenure
- Higher agreement value compared to previous arrangement
Contract Term: Three (3) years from Effective Date (24th August, 2026)
Termination/Revision Clause: May be revised or terminated with 6 months' notice prior to expiry or extended expiry
Financial Value: AUD 30 million (approximately ₹204 crores at exchange rate of ₹68.52)
Related Party Considerations
Promoter/Group Interest: No, the promoter/promoter group/group companies do not have any interest in the entity that awarded the order/contract
Related Party Transaction: No, the order/contract would not fall within related party transactions